MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41392-024-01824-1

Медицинская библиотека · Signal transduction and targeted therapy · 2024

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.

Fu Rao, Qi Ruoyao, Xiong Hualong, Lei Xing, Jiang Yao, He Jinhang, Chen Feng, Zhang Liang, Qiu Dekui, Chen Yiyi, Nie Meifeng, Guo Xueran, Zhu Yuhe, Zhang Jinlei, Yue Mingxi, Cao Jiali, Wang Guosong, Que Yuqiong, Fang Mujing, Wang Yingbin, Chen Yixin, Cheng Tong, Ge Shengxiang, Zhang Jun, Yuan Quan, Zhang Tianying, Xia Ningshao

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Antitumor therapies based on adoptively transferred T cells or oncolytic viruses have made significant progress in recent years, but the limited efficiency of their infiltration into solid tumors makes it difficult to achieve desired antitumor effects when used alone. In this study, an oncolytic virus (rVSV-LCMVG) that is not prone to induce virus-neutralizing antibodies was designed and combined with adoptively transferred T cells. By transforming the immunosuppressive tumor microenvironment into an immunosensitive one, in B16 tumor-bearing mice, combination therapy showed superior antitumor effects than monotherapy. This occurred whether the OV was administered intratumorally or intravenously. Combination therapy significantly increased cytokine and chemokine levels within tumors and recruited CD8+ T cells to the TME to trigger antitumor immune responses. Pretreatment with adoptively transferred T cells and subsequent oncolytic virotherapy sensitizes refractory tumors by boosting T-cell recruitment, down-regulating the expression of PD-1, and restoring effector T-cell function. To offer a combination therapy with greater translational value, mRNA vaccines were introduced to induce tumor-specific T cells instead of adoptively transferred T cells. The combination of OVs and mRNA vaccine also displays a significant reduction in tumor burden and prolonged survival. This study proposed a rational combination therapy of OVs with adoptive T-cell transfer or mRNA vaccines encoding tumor-associated antigens, in terms of synergistic efficacy and mechanism.

Для цитирования: Fu Rao, Qi Ruoyao, Xiong Hualong, Lei Xing, Jiang Yao, He Jinhang, Chen Feng, Zhang Liang, Qiu Dekui, Chen Yiyi, Nie Meifeng, Guo Xueran, Zhu Yuhe, Zhang Jinlei, Yue Mingxi, Cao Jiali, Wang Guosong, Que Yuqiong, Fang Mujing, Wang Yingbin, Chen Yixin, Cheng Tong, Ge Shengxiang, Zhang Jun, Yuan Quan, Zhang Tianying, Xia Ningshao. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.. Signal transduction and targeted therapy. 2024. DOI: 10.1038/s41392-024-01824-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.